<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Basic and Clinical Neuroscience Journal</title>
<title_fa>مجله علوم اعصاب پایه و بالینی</title_fa>
<short_title>BCN</short_title>
<subject>Medical Sciences</subject>
<web_url>http://bcn.iums.ac.ir</web_url>
<journal_hbi_system_id>137</journal_hbi_system_id>
<journal_hbi_system_user>journal137</journal_hbi_system_user>
<journal_id_issn>2008-126X</journal_id_issn>
<journal_id_issn_online>2228-7442</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi>10.32598/bcn</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid></journal_id_sid>
<journal_id_nlai></journal_id_nlai>
<journal_id_science></journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1399</year>
	<month>4</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2020</year>
	<month>7</month>
	<day>1</day>
</pubdate>
<volume>11</volume>
<number>4</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Role of Nitric Oxide in the Antipruritic Effect of WIN 55,212-2, a Cannabinoid Agonist</title>
	<subject_fa>Behavioral Neuroscience</subject_fa>
	<subject>Behavioral Neuroscience</subject>
	<content_type_fa>Original</content_type_fa>
	<content_type>Original</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;div style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Introduction&lt;/strong&gt;: For centuries, cannabinoids are known to be effective in pain relief. Itch is an unpleasant sensation that provokes a desire to scratch. Since itch and pain are two sensations sharing a lot in common, we aimed to investigate whether the cannabinoid agonist WIN 55,212-2 reduces serotonin-induced scratching behavior and also observe whether modulation of nitric oxide (NO) production mediates the antipruritic effect of WIN 55,212-2.&lt;br&gt;
&lt;strong&gt;Methods&lt;/strong&gt;: Scratching behavior is induced by intradermal injection of serotonin (50 &amp;micro;g/50 &amp;micro;L/mouse) to BALB/c mice. The cannabinoid agonist WIN 55,212-2 (1, 3, 10 mg/kg, IP) was given 30 min before serotonin injection. To observe the effect of NO modulation on the antipruritic effect of cannabinoids, the endothelial nitric oxide synthase (NOS) inhibitor L-NAME (3 mg/kg, IP), the neuronal NOS inhibitor 7-nitroindazole (3 mg/kg, IP), and the NO precursor L-arginine (100 mg/kg, IP) were administered together with WIN 55,212-2.&amp;nbsp;&lt;br&gt;
&lt;strong&gt;Results&lt;/strong&gt;: WIN 55,212-2 reduced serotonin-induced scratches at higher doses (3, 10 mg/kg; P&lt;0.0001). The endothelial NOS inhibitor L-NAME, the neuronal NOS inhibitor 7-nitroindazole, and the nitric oxide precursor L-arginine did not influence the antipruritic action of WIN 55,212-2. When NO modulators were used alone, only the neuronal NOS inhibitor 7-nitroindazole attenuated serotonin-induced scratches (P&lt;0.0001).&lt;br&gt;
&lt;strong&gt;Conclusion&lt;/strong&gt;: Our findings indicate that exogenous cannabinoids may attenuate serotonin-induced scratches and NO does not mediate the antipruritic effect of WIN 55,212-2. On the other hand, neuronal NOS inhibition may play a role in the production of serotonin-induced scratches.&lt;/div&gt;</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Cannabinoid system, Nitric oxide, Pruritus, Serotonin, WIN 55,212-2</keyword>
	<start_page>473</start_page>
	<end_page>480</end_page>
	<web_url>http://bcn.iums.ac.ir/browse.php?a_code=A-10-1348-1&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Oyku Zeynep</first_name>
	<middle_name></middle_name>
	<last_name>Gercek</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>oykuzeynepgercek@gmail.com</email>
	<code>13700319475328460028776</code>
	<orcid>13700319475328460028776</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Medical Pharmacology, Faculty of Medicine, Trakya University, Turkey.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Busra</first_name>
	<middle_name></middle_name>
	<last_name>Oflaz</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>busraoflaz@hotmail.com</email>
	<code>13700319475328460028777</code>
	<orcid>13700319475328460028777</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Medical Pharmacology, Faculty of Medicine, Trakya University, Turkey.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Neslihan</first_name>
	<middle_name></middle_name>
	<last_name>Oguz</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>neslihan_ogz@hotmail.com</email>
	<code>13700319475328460028778</code>
	<orcid>13700319475328460028778</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Medical Pharmacology, Faculty of Medicine, Trakya University, Turkey.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Koray</first_name>
	<middle_name></middle_name>
	<last_name>Demirci</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>koraydemirci6@hotmail.com</email>
	<code>13700319475328460028779</code>
	<orcid>13700319475328460028779</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Medical Pharmacology, Faculty of Medicine, Trakya University, Turkey.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Ozgur</first_name>
	<middle_name></middle_name>
	<last_name>Gunduz</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>gunduz_ozgur@yahoo.com</email>
	<code>13700319475328460028780</code>
	<orcid>13700319475328460028780</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Medical Pharmacology, Faculty of Medicine, Trakya University, Turkey.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Ahmet</first_name>
	<middle_name></middle_name>
	<last_name>Ulugol</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>aulugol@trakya.edu.tr</email>
	<code>13700319475328460028781</code>
	<orcid>13700319475328460028781</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Department of Medical Pharmacology, Faculty of Medicine, Trakya University, Turkey.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
